Perspective: Prevention is better than cure

Nature

Volumn 475, Issue 7355 SUPPL., 2011, Pages

  Gandy, Sam ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; COGNITIVE DEFECT; GENE INSERTION; GENE MUTATION; HUMAN; IMMUNOTHERAPY; NEUROTOXICITY; NONHUMAN; NOTE; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MICE; MIDDLE AGED; PLAQUE, AMYLOID; TIME FACTORS;

EID: 79960347757     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/475S15a     Document Type: Note

References (7)

1. Terry, R. D. & Katzman, R. Ann. Neurol. 14, 497-506 (1983).
2. Bertram, L., Lill, C. M. & Tanzi, R. E. Neuron 68, 270-281 (2010).
3. Gandy, S. J. Clin. Invest. 115, 1121-1129 (2005).
4. Klunk, W. E. et al. Ann. Neurol. 55, 306-319 (2004).
5. Rinne, J. O. et al. Lancet Neurol. 9, 363-372 (2010).
6. Knight, W. D. et al. Brain 134, 293-300 (2011).
7. Sperling, R. A. et al. Alzheimers Dement. 7, 280-292 (2011).